Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and

Aleksandra K Wierzbowski1, James A Karlowsky, Heather J Adam

  • 1Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.

Abstract

Insights

Macrolide-resistant Streptococcus pneumoniae (MRSP) in Canada increased significantly from 1998 to 2008. This rise was driven by non-PCV7 serotypes, particularly 19A, which showed increased multidrug resistance and spread.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance Surveillance

Background:

  • Macrolide-resistant Streptococcus pneumoniae (MRSP) poses a significant public health threat.
  • Understanding resistance mechanisms and serotype distribution is crucial for effective treatment and prevention strategies.
  • Surveillance data from 1998-2008 in Canada provides a decade-long perspective on MRSP trends.

Purpose of the Study:

  • To investigate resistance mechanisms, multidrug resistance (MDR), and genetic relatedness of MRSP.
  • To determine serotype distribution and heptavalent pneumococcal conjugate vaccine (PCV7) coverage.
  • To assess the prevalence of pili virulence factors among MRSP isolates.

Main Methods:

  • Analysis of 1518 MRSP isolates from Canadian national surveillance studies (CROSS and CANWARD).
  • Antimicrobial susceptibility testing using broth microdilution.
  • Detection of macrolide resistance genes (mef(A), erm(B)), pili virulence factors, serotyping (Quellung reaction), and genetic relatedness (PFGE).

Main Results:

  • MRSP prevalence increased from 8% to 22% between 1998 and 2008 (P = 0.0001).
  • Dual mef(A)- and erm(B)-positive isolates rose from 3% to 19% (P = 0.001), alongside a decrease in PCV7 serotypes (67% to 31%).
  • Serotype 19A, a non-PCV7 type, increased by 15% and was associated with MDR, dual resistance genes, genetic relatedness, and pili factors.

Conclusions:

  • Significant increase in MRSP respiratory isolates in Canada from 1998-2008.
  • Emergence and spread of non-PCV7 serotypes, particularly 19A, are primary drivers of this increase.
  • Serotype 19A isolates exhibit concerning characteristics including MDR and presence of virulence factors.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Evolution of Microbial Genome01:08

Evolution of Microbial Genome

Microbial genome evolution is a highly dynamic process shaped by continual gene gain and loss across species and strains. This genomic flexibility allows microorganisms to adapt rapidly to environmental pressures and interactions with other organisms. Central to understanding this diversity is the distinction between the core and pan genomes.The core genome comprises the genes shared by all sampled strains of a species, representing essential functions needed for fundamental cellular processes.
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...